VE202

· Vedanta Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VE202, covering 2025-12-17 to 2025-12-17. Get the full timeline:

Most recent: Clinical Trial Update: VE202 in Patients With Mild-to-Moderate Ulcerative Colitis [Phase 2]